VCs target pain treatments, but without the opioids

Opioid VC Venture
Ken Hood, managing director at FusionX Ventures, knows how easily good people can fall into the addiction trap. Not long ago, he spent a week in hospital due to complications from knee surgery. “I can’t tell you how many times ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.

Digital Edition


To read a digital copy of our latest magazine

click here